AC8 1.92% 13.3¢ auscann group holdings ltd

where to next?, page-992

  1. 287 Posts.
    lightbulb Created with Sketch. 44
    Will see if this little pop last till tomorrow. I read the presentation and it was nothing new! They almost took the old one and changed a tiny bit for the new presentation. The only thing new is the picture of a box of their proposed product with a name on it. They did not show any sample capsule or artwork of it. They claim that gel capsules on the market are not good. But they did not say anything about what makes their proposed capsule different from the gel capsules on the market. I hope some one asked them the question during the presentation and post the answer here for us to know. Also, they talk about possible target for the capsules to be available mid 2019 for clinical trials, yet they did not talk about any working on arrangements for trials. Does this mean they need to prove to themselves that it's possible to make the capsules by mid 2019 and then they will start making arrangements for trials? This would push it further into 2020 before any trial can be started. It looks like self-doubt running inside this company. Again, I hope some one at the presentation asked the question why there was no arrangement for trials.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.